4ZAE image
Deposition Date 2015-04-13
Release Date 2015-06-03
Last Version Date 2024-10-16
Entry Detail
PDB ID:
4ZAE
Keywords:
Hydrolase/Hydrolase Inhibitor
Title:
Development of a novel class of potent and selective FIXa inhibitors
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.86 Å
R-Value Free:
0.17
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
H 3
4ZAE validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Coagulation factor IX
Gene (Uniprot):F9
Mutations:R150A
Chain IDs:A
Chain Length:235
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P00740 Pfam ID:PF00089, PF14670 EC:3.4.21.22
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Coagulation factor IX
Gene (Uniprot):F9
Chain IDs:B
Chain Length:62
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P00740 Pfam ID:PF00089, PF14670 EC:3.4.21.22
Primary Citation
Development of a novel class of potent and selective FIXa inhibitors.
Bioorg.Med.Chem.Lett. 25 4945 4949 (2015)
PMID: 25978966 DOI: 10.1016/j.bmcl.2015.04.057

Abstact

Using structure based drug design (SBDD), a novel class of potent coagulation Factor IXa (FIXa) inhibitors was designed and synthesized. High selectivity over FXa inhibition was achieved. Selected compounds demonstrated oral bioavailability in rat IV/PO pharmacokinetic (PK) studies. Finally, the pharmacodynamics (PD) of this class of molecules was evaluated in Thrombin Generation Assay (TGA) in Corn Trypsin Inhibitor (CTI) citrated human plasma and demonstrated characteristics of a FIXa inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
4ZAE